Selected article for: "acceptability testing and low resource"

Author: Xiao, Yinzong; Thompson, Alexander J.; Howell, Jessica
Title: Point-of-Care Tests for Hepatitis B: An Overview
  • Cord-id: wj7r6953
  • Document date: 2020_10_2
  • ID: wj7r6953
    Snippet: Despite the heavy disease burden posed by hepatitis B, around 90% of people living with hepatitis B are not diagnosed globally. Many of the affected populations still have limited or no access to essential blood tests for hepatitis B. Compared to conventional blood tests which heavily rely on centralised laboratory facilities, point-of-care testing for hepatitis B has the potential to broaden testing access in low-resource settings and to engage hard-to-reach populations. Few hepatitis B point-o
    Document: Despite the heavy disease burden posed by hepatitis B, around 90% of people living with hepatitis B are not diagnosed globally. Many of the affected populations still have limited or no access to essential blood tests for hepatitis B. Compared to conventional blood tests which heavily rely on centralised laboratory facilities, point-of-care testing for hepatitis B has the potential to broaden testing access in low-resource settings and to engage hard-to-reach populations. Few hepatitis B point-of-care tests have been ratified for clinical use by international and regional regulatory bodies, and countries have been slow to adopt point-of-care testing into hepatitis B programs. This review presents currently available point-of-care tests for hepatitis B and their roles in the care cascade, reviewing evidence for testing performance, utility, acceptability, costs and cost-effectiveness when integrated into hepatitis B diagnosis and monitoring programs. We further discuss challenges and future directions in aspects of technology, implementation, and regulation when adopting point-of-care testing in hepatitis B programs.

    Search related documents:
    Co phrase search for related documents
    • active infection and liver cirrhosis: 1, 2
    • active infection and liver damage: 1, 2
    • active infection and liver disease: 1, 2, 3, 4, 5
    • active infection and liver disease stage: 1
    • active infection and liver function: 1, 2, 3, 4
    • active infection and liver function test: 1
    • active infection and liver inflammation: 1
    • active infection and low income: 1, 2, 3, 4, 5, 6, 7, 8
    • active infection and low income country: 1, 2
    • liver disease and low accuracy: 1
    • liver disease and low income: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • liver disease and low middle: 1, 2, 3, 4, 5
    • liver disease and low resource: 1, 2
    • liver disease and low sensitivity: 1, 2
    • liver function and low income: 1, 2, 3
    • liver function and low income country: 1
    • liver function and low middle: 1, 2, 3
    • liver function and low middle resource: 1
    • liver function and low resource: 1